Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed Nov 5, 2012 · 10-Q · 36 days after period end · 0001193125-12-451641
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Net Income | -$6.12M | -$4.20M | -$1.67M |
| EPS Diluted | -$0.45 | -$0.02 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 5, 2012 · 36 d after period end
